Anshan Pharmaceutical

Anshan Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company and a key subsidiary of the Lonch Group (Langzhi Group). Based in Anshan, Liaoning, the company specializes in the development and manufacturing of both Traditional Chinese Medicines (TCM) and chemical pharmaceuticals, with a particular focus on cardiovascular, cerebrovascular, and gastrointestinal health. Its flagship products, such as the Xin Xue Ning Tablet and Beidougen Tablets, are widely recognized in the Chinese market for treating conditions like coronary heart disease and respiratory infections. The company operates modern production facilities that are fully GMP-certified and holds numerous state-level patents and national drug protection designations. Anshan Pharmaceutical serves as one of the primary manufacturing hubs for the Lonch Group's extensive portfolio of over 500 drug approvals.